SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES) in a report issued on Thursday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright boosted their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.

SenesTech Stock Down 0.6 %

SNES stock opened at $1.79 on Thursday. SenesTech has a 52 week low of $1.72 and a 52 week high of $9.80. The business has a 50-day simple moving average of $2.75 and a 200 day simple moving average of $2.75. The company has a quick ratio of 4.92, a current ratio of 6.32 and a debt-to-equity ratio of 0.05. The company has a market cap of $3.13 million, a PE ratio of -0.18 and a beta of 0.09.

SenesTech (NASDAQ:SNES) last released its earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, beating the consensus estimate of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The firm had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.71 million. Sell-side analysts anticipate that SenesTech will post -10.22 EPS for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.